Details
| Stereochemistry | MIXED |
| Molecular Formula | C22H33NO5 |
| Molecular Weight | 391.5011 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 6 |
| E/Z Centers | 2 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC(C)[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2O\C(C[C@H]12)=C(/CCCC(O)=O)C#N
InChI
InChIKey=OJIGXQJDLFUVFM-MBLRWRSDSA-N
InChI=1S/C22H33NO5/c1-3-4-6-14(2)18(24)10-9-16-17-11-20(28-21(17)12-19(16)25)15(13-23)7-5-8-22(26)27/h9-10,14,16-19,21,24-25H,3-8,11-12H2,1-2H3,(H,26,27)/b10-9+,20-15+/t14?,16-,17-,18-,19-,21+/m1/s1
| Molecular Formula | C22H33NO5 |
| Molecular Weight | 391.5011 |
| Charge | 0 |
| Count |
|
| Stereochemistry | EPIMERIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 5 / 6 |
| E/Z Centers | 2 |
| Optical Activity | UNSPECIFIED |
Nileprost is a prostacyclin analogue stabilized by introduction of the cyano group at its 5-position. Nileprost is a mixed type PGI2/PGE2 agonist. The development of the prostaglandin analogue nileprost [ZK 34798] for use in peptic ulcers has been discontinued at phase II by Schering AG in Germany.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Degradation and isomerization of nileprost, 5-cyano-16-methyl-prostacyclin, in aqueous solution. | 1990-09 |
|
| Influence of some prostaglandins and prostaglandin analogues on PAF-induced shock in mice. | 1990-06 |
|
| Influence of prostaglandins and PG-analogues on the mortality of PAF-acether in mice and the TXB2 release from human granulocytes. | 1988 |
|
| Development of a radioimmunoassay and its application to the pharmacokinetics of the stable prostacyclin analogue, nileprost, in the rat. | 1984-04 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2441164
Nileprost (0.5 ug/kg/min intravenously, i.v.) protected the left ventricular myocardium of cats subjected to 5 h of coronary artery ligation from ischemic injury.
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2441164
Isolated bovine coronary arteries were relaxed by Nileprost at low concentrations (less than 3 uM), whereas higher concentrations produced a marked vasoconstriction.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:48:30 GMT 2025
by
admin
on
Mon Mar 31 18:48:30 GMT 2025
|
| Record UNII |
YGD81BG4SN
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C78568
Created by
admin on Mon Mar 31 18:48:30 GMT 2025 , Edited by admin on Mon Mar 31 18:48:30 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID501024482
Created by
admin on Mon Mar 31 18:48:30 GMT 2025 , Edited by admin on Mon Mar 31 18:48:30 GMT 2025
|
PRIMARY | |||
|
C76901
Created by
admin on Mon Mar 31 18:48:30 GMT 2025 , Edited by admin on Mon Mar 31 18:48:30 GMT 2025
|
PRIMARY | |||
|
100000083881
Created by
admin on Mon Mar 31 18:48:30 GMT 2025 , Edited by admin on Mon Mar 31 18:48:30 GMT 2025
|
PRIMARY | |||
|
71097-83-1
Created by
admin on Mon Mar 31 18:48:30 GMT 2025 , Edited by admin on Mon Mar 31 18:48:30 GMT 2025
|
PRIMARY | |||
|
YGD81BG4SN
Created by
admin on Mon Mar 31 18:48:30 GMT 2025 , Edited by admin on Mon Mar 31 18:48:30 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104724
Created by
admin on Mon Mar 31 18:48:30 GMT 2025 , Edited by admin on Mon Mar 31 18:48:30 GMT 2025
|
PRIMARY | |||
|
6436100
Created by
admin on Mon Mar 31 18:48:30 GMT 2025 , Edited by admin on Mon Mar 31 18:48:30 GMT 2025
|
PRIMARY | |||
|
C038832
Created by
admin on Mon Mar 31 18:48:30 GMT 2025 , Edited by admin on Mon Mar 31 18:48:30 GMT 2025
|
PRIMARY | |||
|
SUB09287MIG
Created by
admin on Mon Mar 31 18:48:30 GMT 2025 , Edited by admin on Mon Mar 31 18:48:30 GMT 2025
|
PRIMARY | |||
|
4971
Created by
admin on Mon Mar 31 18:48:30 GMT 2025 , Edited by admin on Mon Mar 31 18:48:30 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |